Home / Editorial Team / Delthia Ricks
Delthia Ricks

Delthia Ricks

Author

Delthia Ricks is an award-winning science writer and author with stories published in Newsday, Discover Magazine, and the Journal of the National Cancer Institute. She has written four books, most recently "100 Questions and Answers About Coronaviruses." She holds degrees from UCLA and Columbia University, with an M.S. in Biology.

Articles by Delthia Ricks

Medical Xpress / Fibrosis lacks treatments and methods of reversal: Study pinpoints a promising target for drug therapy

Medical science has long been on the hunt for a deeper understanding of the devastating scarring of the body's organs known as fibrosis, which leads to irrevocable loss of function.

Sep 23, 2024
Medical Xpress / Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

Artificial intelligence is being used in a wide variety of applications in medicine, and now scientists have developed an AI system that can boost detection rates for cancerous and precancerous lesions of the esophagus, which ...

Jul 31, 2024
Medical Xpress / Front-line drug for ulcerative colitis found to have additional mechanism of action that until now remained elusive

Monoclonal antibodies have become indispensable in medicine to combat cancers, infectious diseases and autoimmune disorders. But the mechanism of action of a major monoclonal antibody developed for ulcerative colitis has ...

Jul 23, 2024
Medical Xpress / Scientists developing a monoclonal antibody to neutralize Nipah virus one of the deadliest zoonotic pathogens

An experimental monoclonal antibody has been engineered to target the deadly Nipah virus, an emerging zoonotic pathogen with a human mortality rate ranging as high as a staggering 90%.

Jun 29, 2024
Medical Xpress / A new look at why old age is linked to severe, even fatal COVID

A longstanding question has nagged the COVID battle for more than four years: Why does the infection cause severe disease in older people? The question has remained despite a global cadre of medical investigators having produced ...

Jun 15, 2024
Medical Xpress / Doctors develop minimally invasive procedure to avoid drilling a 'burr hole' in the skull to treat clot on the brain

In 2018, a New York surgeon-scientist and his team demonstrated in a proof-of-concept study that a minimally invasive procedure could effectively treat one of the world's most common conditions requiring neurosurgical intervention.

Jun 4, 2024
Medical Xpress / Scientists demystify why subsequent bouts of dengue are worse than a first-time infection

A massive upsurge in dengue cases marked by multiple outbreaks is occurring worldwide and raising new questions about who is at elevated risk of severe forms of the mosquito-transmitted disease.

May 14, 2024
Medical Xpress / An infamous 'inflammasome'—a rogue protein complex—appears to underlie a rare and disabling autoimmune disorder

Autoimmune diseases are among the most puzzling because turncoat constituents of the body wage a constant state of war. Sometimes the underlying cause of an autoimmune condition is so obscure—hidden within chemical miscues ...

Mar 29, 2024
Medical Xpress / Scientists consider fighting potentially lethal form of breast cancer with chemical produced by the disease

Triple negative breast cancer is the most aggressive subtype of the disease and is notorious for a poor prognosis, but scientists are working on a breakthrough method of converting these treatment-resistant tumors into a ...

Mar 22, 2024
Medical Xpress / How does vaccination thwart pneumococcal infection? Animal model uncovers 'capture and kill' scenario

In findings that are nothing short of surprising, scientists have demonstrated that the liver is the site where the immune system unleashes its assault on pneumococcal bacteria following vaccination against the potentially ...

Feb 28, 2024
Medical Xpress / Elusive immune cells dwelling in 'hidden niches' of the bone marrow may be key to SARS-CoV-2 vaccination

Although immunologists have developed a deep reservoir of knowledge illuminating how antibodies respond to vaccination against SARS-CoV-2, little is known about the elusive cells that produce infection-fighting antibodies.

Feb 27, 2024
Medical Xpress / Can an experimental cell phone app screen coughs for TB? Scientists say 'yes'

What telltale features—many inaudible to the human ear—separate one kind of cough from another? Scientists are on the verge of finding out with a new machine learning tool aimed at identifying the signature sounds of tuberculosis.

Feb 7, 2024
Medical Xpress / New form of immunotherapy under investigation for cancer that resists conventional T cell therapies

Medical investigators are theorizing that a combination of two treatments that activate myeloid cells may effectively treat a recalcitrant form of pancreatic cancer that thwarts conventional immunotherapy.

Dec 28, 2023
Medical Xpress / Scientists solve 18-year-old mystery and find the once-elusive source of a critical T cell population

One of the more rigorous debates in immunology has centered on the origin of an enigmatic T cell population that possesses properties imparting memory and stem cell–like qualities, but facts about their genesis were so elusive ...

Dec 28, 2023
Medical Xpress / Gut microbes may determine patients' response to a drug that delays onset of type 1 diabetes

The microbiome offers a motherlode of data about health and disease, and new findings suggest that antibodies to gut microbes can determine how well patients respond to a new monoclonal antibody drug that delays the onset ...

Dec 27, 2023